MYUNGMOON Pharm co.,Ltd reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 2,836.73 million compared to negative sales of KRW 6,560.39 million a year ago. Net income was KRW 2,176.02 million compared to KRW 656.59 million a year ago. Basic earnings per share from continuing operations was KRW 64 compared to KRW 19 a year ago. Diluted earnings per share from continuing operations was KRW 64 compared to KRW 19 a year ago. Basic earnings per share was KRW 64 compared to KRW 18 a year ago.
For the six months, sales was KRW 4,163.25 million compared to KRW 3,316.65 million a year ago. Net income was KRW 3,141.31 million compared to KRW 1,274.55 million a year ago. Basic earnings per share from continuing operations was KRW 93 compared to KRW 38 a year ago. Diluted earnings per share from continuing operations was KRW 93 compared to KRW 38 a year ago. Basic earnings per share was KRW 93 compared to KRW 38 a year ago.